Dual-isocenter MR-Linac workflow treats 24-cm prostate and pelvic targets in one patient
A dual-isocenter MR-Linac workflow treated a 24-cm continuous prostate and pelvic target, achieving high gamma passing rates in its first clinical application.
Research updates & The Weekly Five
New research summaries with key findings, limitations and links to the original papers. Five selected studies in your inbox every Sunday, free.
Curated by Alexey Cherchik, MDRadiation oncologist | Founder and editor
A dual-isocenter MR-Linac workflow treated a 24-cm continuous prostate and pelvic target, achieving high gamma passing rates in its first clinical application.
In cervical cancer, MRI-based brachytherapy was associated with better survival versus historical techniques, but superiority over contemporary CT-guided brachytherapy remained unproven.
Pooled five-year disease-control survival was 81.0% after 23.4-Gy CSI versus 71.3% after 18 Gy, supporting caution with further dose reduction.
Vacuum mattress positioning reduced between-session mean-temperature variability from 0.65°C to 0.40°C during superficial hyperthermia in 24 patients.
In 60 patients, adding dosiomic features improved xerostomia prediction only modestly, with a best AUC of 0.60 and no statistically significant advantage.
Across 2,090 patients with residual esophageal squamous cell carcinoma, adjuvant immunotherapy was associated with improved disease-free survival, while overall survival benefit remained uncertain.
In a 102-patient randomized trial, megestrol improved post-RT weight change by 3.81 kg versus standard care, predominantly through increased fat mass.
In dogs with presumed glioma, single-fraction 10 Gy reduced MRI-defined tumor volume, while 15 Gy was associated with suspected radiation injury.
A narrative review distinguishes established glioma radiotherapy evidence from experimental radiosensitization, proton therapy, FLASH, and adaptive treatment strategies.
Among 183 radiotherapy patients, 36.6% perceived less treatment-related stress from electronic symptom monitoring, and 68.4% wanted to continue using the platform.
Among 89 breast cancer patients with at least three positive sentinel nodes, lymphedema was 3.1% with nodal irradiation versus 21.1% after axillary dissection.
In 378 prostate cancer patients, ten-year biochemical control was 79.6% with one HDR boost fraction versus 82.6% with two, while severe urinary toxicity differed.
After five years, biochemical control was 80.5% with single-fraction 24 Gy versus 85.1% with five-fraction 45 Gy, without proven equivalence.
In 271 recurrent glioblastoma patients, SRS doses above 19 Gy were associated with longer post-recurrence survival, without a demonstrated progression-free survival benefit.
The Hong Kong SBRT Study Group recommends risk-adapted local therapy for selected oncogene-driven NSCLC, including oligoresidual, oligoprogressive, and intracranial disease.
Browse by editorial relevance or explore a topic.
Relevance labels describe editorial importance. Study design and limitations determine how to interpret the evidence.
Five selected studies, emailed every Sunday, free.